Kisqali and Arsenic trioxide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Kisqali (ribociclib succinate) and Arsenic trioxide (arsenic trioxide). Common drug interactions include electrocardiogram qt prolonged among females.

The phase IV clinical study analyzes what interactions people have when they take Kisqali and Arsenic trioxide. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Kisqali?

Kisqali has active ingredients of ribociclib succinate. eHealthMe is studying from 25,050 Kisqali users. Check the latest studies of Kisqali.

What is Arsenic trioxide?

Arsenic trioxide has active ingredients of arsenic trioxide. eHealthMe is studying from 990 Arsenic trioxide users. Check the latest studies of Arsenic trioxide.



On Aug, 01, 2026

31 people who take Kisqali and Arsenic trioxide together, and have interactions are studied.

Kisqali and Arsenic trioxide drug interactions.

What are the common drug interactions of Kisqali and Arsenic Trioxide, by gender? *:

female:

  1. Electrocardiogram qt prolonged

male:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Kisqali and Arsenic trioxide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Kisqali and Arsenic trioxide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Kisqali:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Arsenic trioxide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kisqali and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Arsenic trioxide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ribociclib succinate and arsenic trioxide (the active ingredients of Kisqali and Arsenic trioxide, respectively), and Kisqali and Arsenic trioxide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: